Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Protein Variants

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 147 > >>
EC Number Protein Variants Commentary Reference
Show all pathways known for 3.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.1A115V activity in U2OS cells after 48h after transfection: 0.1% 694196
Show all pathways known for 3.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.1A116T mutant responsible for hypophosphatasia shows negligible alkaline phosphatase activity and a weak dominant negative effect when co-expressed with the wild-type enzyme, mutant exists as a monomer and heterogeneously associated aggregates covalently linked via disulfide bonds in contrast to wild-type enzyme which exists as a homodimer 714341
Show all pathways known for 3.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.1A16V in combination with P275T the mutation causes infantile hypophosphatasia, 7.2% of wild-type activity 666373
Show all pathways known for 3.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.1biotechnology aqueous suspendible polymer nanostructures are prepared by simple microtome processing of electrospun nylon 6 nanofibers and are used to immobilize calf intestinal ALP by either covalent or noncovalent bioconjugation chemistries. Noncovalent immobilization of ALP to the mechanically cut nanofibers using a multi-stacked, layer-by-layer approach with the cationic polymer Sapphire II results in the highest enzyme loading. In terms of the overall catalytic performance of the various immobilized ALP systems, a single-stacked layer-by-layer assembly approach resulted in the highest level of enzymatic activity (30.1%) per unit mass of nanofiber support 693963
Show all pathways known for 3.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.1C201Y mutation identified in patient diagnosed with perinatal hypophosphatasia. Mutants exhibit a diminished alkaline phosphatase activity in the cells, where a 66 kDa immature form is predominant with a marginal amount of a 80 kDa mature form. The 66 kDa form exists as a monomer in contrast to a dimer form of wild-type. Only a small fraction of the mutant protein reaches cell surface as the 80 kDa mature form, most of the 66 kDa form is found to be endo-beta-N-acetylglucosaminidase H sensitive and rapidly degraded in proteasome following polyubiquitination 729280
Show all pathways known for 3.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.1C489S mutation identified in patient diagnosed with perinatal hypophosphatasia. Mutants exhibit a diminished alkaline phosphatase activity in the cells, where a 66 kDa immature form is predominant with a marginal amount of a 80 kDa mature form 729280
Show all pathways known for 3.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.1D101A the mutant shows 64fold decreased catalytic efficiency compared to the wild type enzyme 750399
Show all pathways known for 3.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.1D101A/D153A the mutant shows 190fold decreased catalytic efficiency compared to the wild type enzyme 750399
Show all pathways known for 3.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.1D101A/D153A/E322Y the mutant shows 48000000fold decreased catalytic efficiency compared to the wild type enzyme 750399
Show all pathways known for 3.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.1D101A/D153A/E322Y/K328A the mutant shows 320000000fold decreased catalytic efficiency compared to the wild type enzyme 750399
Results 1 - 10 of 147 > >>